Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Profound Medical Corp. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 45 | 42 | −3 |
| Shares | 9.25M | 9.52M | +265.1K (+2.9%) |
| Value | $77.8M | $80.3M | +$2.53M (+3.3%) |
New holders (5)
Institutions that held Profound Medical Corp. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ardsley Advisory Partners LP | 145,000 | $1.24M | 0.18% |
| Cetera Investment Advisers | 11,769 | $100.4K | 0.00% |
| UBS Group AG | 645 | $5.50K | 0.00% |
| Allworth Financial LP | 48 | $410 | 0.00% |
| Simplex Trading, LLC | 87 | $0 | 0.00% |
Sold out (8)
Institutions that held Profound Medical Corp. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Worth Venture Partners, LLC | 160,971 | $1.37M |
| Kepos Capital LP | 100,000 | $849.0K |
| Cetera Advisor Networks LLC | 11,669 | $98.2K |
| Schonfeld Strategic Advisors LLC | 11,200 | $95.1K |
| Levin Capital Strategies, L.P. | 10,000 | $84.9K |
| FNY Investment Advisers, LLC | 8,000 | $67.0K |
| JPMorgan Chase & Co | 1,503 | $12.8K |
| Cape Investment Advisory, Inc. | 231 | $1.96K |